Rajangam Kanya 4
4 · Turnstone Biologics Corp. · Filed Oct 17, 2023
Insider Transaction Report
Form 4
Rajangam Kanya
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-16+8,012→ 8,012 totalExercise: $2.61Exp: 2033-10-15→ Common Stock (8,012 underlying)
Footnotes (1)
- [F1]Thirty three and thirty three one hundreds percent (33.33%) (and thirty three and thirty four one hundreds percent (33.34%) for year three) of the shares subject to the option will vest in three (3) annual installments commencing on the date of the first annual general meeting of stockholders occurring after October 12, 2023, subject to the Reporting Person's continuous service through each such vesting date.